LifeScan CEO Valerie Asbury said on social media today that she is retiring from the glucose management technology developer.

MyLife Diabetes Care announced that its transition into an independent company has now been formally completed.

The site, in Lehigh Valley, will serve as the company’s newest injectable medicine and device manufacturing facility. Indianapolis-based Lilly plans to produce next-generation weight-loss therapies ...

Senseonics (NYSE:SENS) announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark ...

Glucotrack (Nasdaq:GCTK) announced today that it received new U.S. patents for its continuous blood glucose monitoring (CBGM) ...

Insulin patch pump maker ViCentra announced today that it appointed Reman McDonagh as its VP, global marketing.

CraniUS Therapeutics announced today that it raised $20 million in a Series B financing round to accelerate the development ...

Glaukos (NYSE:GKOS) announced today that the FDA approved a new drug application (NDA) labeling supplement for its iDose TR ...